Vestor Capital LLC Sells 2,300 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Vestor Capital LLC lowered its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 48.9% in the 4th quarter, Holdings Channel reports. The firm owned 2,401 shares of the pharmacy operator’s stock after selling 2,300 shares during the quarter. Vestor Capital LLC’s holdings in Walgreens Boots Alliance were worth $63,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC boosted its stake in Walgreens Boots Alliance by 308.4% during the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after buying an additional 845 shares during the period. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter worth approximately $26,000. Venturi Wealth Management LLC raised its stake in Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 981 shares in the last quarter. Rocky Mountain Advisers LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter valued at approximately $30,000. Finally, Tyler Stone Wealth Management grew its stake in Walgreens Boots Alliance by 1,280.0% in the 3rd quarter. Tyler Stone Wealth Management now owns 1,380 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 1,280 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Insider Buying and Selling at Walgreens Boots Alliance

In related news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at approximately $3,235,859.22. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CFO Manmohan Mahajan acquired 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction dated Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a report on Tuesday, March 26th. Morgan Stanley cut their price objective on Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating for the company in a report on Monday, April 1st. Deutsche Bank Aktiengesellschaft decreased their price objective on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a report on Wednesday, April 3rd. SVB Leerink cut their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Finally, Leerink Partnrs reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Four analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Trading Up 0.1 %

Shares of NASDAQ:WBA traded up $0.02 during midday trading on Thursday, hitting $17.25. 6,060,177 shares of the stock traded hands, compared to its average volume of 13,269,616. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The business’s 50 day moving average is $19.35 and its two-hundred day moving average is $21.50. The stock has a market capitalization of $14.88 billion, a PE ratio of -2.46, a P/E/G ratio of 1.10 and a beta of 0.80. Walgreens Boots Alliance, Inc. has a one year low of $17.13 and a one year high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.16 EPS. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 5.80%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently -14.29%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.